Period:

End of Day 1 Minute 5 Minute 10 Minute 15 Minute 30 Minute Hourly Weekly Monthly Yearly

NASDAQ, LIFE - Atyr Pharma Inc

We began operations as a California partnership in 1987 and incorporated in  California in 1989. In 1997 we reincorporated as a Delaware corporation. Our  principal offices are in Carlsbad, California. Our website is  http://www.invitrogen.com. This Annual Report on Form 10-K, our Quarterly  Reports on Form 10-Q, our Current Reports on Form 8-K and any amendments thereto  are made available without charge on our website.  We have made a number of significant acquisitions over the past several years  that have expanded our overall size and the breadth of the products we offer,  including the 2007 acquisition of Cascade Biologics, Inc. and Genomed GmbH, the  2006 acquisition of Sentigen Holding Corp. and the asset purchase of Xcyte  Therapies, Inc. (Xcyte), and the 2005 acquisitions of Dynal Biotech Holding AS  (Dynal), BioSource International, Inc. (BioSource), Caltag Laboratories (Caltag)  and Zymed Laboratories, Inc. (Zymed).  ...

Read SEC Filing on NASDAQ.com »

Sector:	Health Care
Industry:	Biotechnology: Biological Products (No Diagnostic Substances)
P/E Ratio:	N/A
PEG Ratio:	N/A
EPS:	N/A
DivYield:	N/A
PtB:	2.86
PtS:	N/A
EBITDA:	N/A
Shares:	23.84M
Market Cap:	45.29M
52wk range:	1.08 - 2.45